Home › Astrocytoma › Ohio › Cincinnati
Astrocytoma clinical trials in Cincinnati, OH
5 studies for Astrocytoma are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi away
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- Chicago, IL9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Miami, FL7 studies
- Washington, DC6 studies
- Durham, NC6 studies
- Seattle, WA6 studies
- Columbus, OH6 studies
- San Francisco, CA6 studies
- Aurora, CO5 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)27 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Lung Cancer19 studies
- Obesity19 studies
- Prostate Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.